---
schema_version: "secwatch.filing_event.v1"
accession: "0001740797-25-000030"
form_type: "8-K"
ticker: "AVAI"
cik: "0001740797"
company_name: "AVAI BIO, INC."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T16:53:43.226822+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avant Technologies terminates ELOC with GHS Investments, plans new equity line with $2 floor price

## Summary
- Effective May 13, 2025, the company and GHS Investments mutually terminated the July 17, 2024 Equity Financing Agreement (ELOC).
- Termination was based on evaluation that existing terms, including the minimum floor price, no longer aligned with business strategy.
- Company will withdraw its pending Form S-1 and pursue a new ELOC with a higher minimum floor price of $2.00 per share.
- Both parties confirmed no further obligations or liabilities under the terminated agreements.
- New ELOC structure is intended to improve terms, compliance, and shareholder alignment.

## SEC filing metadata
- accession: 0001740797-25-000030
- form_type: 8-K
- ticker: AVAI
- cik: 0001740797
- company_name: AVAI BIO, INC.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740797/000174079725000030/0001740797-25-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740797/000174079725000030/avai_8kmay132025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001740797-25-000030
- JSON: https://secwatch.observer/filing/0001740797-25-000030.json
- Plain text: https://secwatch.observer/filing/0001740797-25-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.